Corcept Therapeutics (CORT) Change in Accrued Expenses (2010 - 2026)
Corcept Therapeutics (CORT) reported Change in Accrued Expenses of $11.13 million for Q3 2026, down 27.6% from $15.37 million a year earlier and down 67.6% from the prior quarter.
Powered by 
Analysis
Corcept Therapeutics (CORT) Change in Accrued Expenses (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Corcept Therapeutics' Change in Accrued Expenses came in at $23.36 million, down 14.6% year-over-year; for FY2025, it was $3.93 million, down 89.7% from FY2024.
- By year, Change in Accrued Expenses came in at $38.24 million in FY2024 (+116.7%), $17.65 million in FY2023 (+503.0%), $2.93 million in FY2022 (-54.8%) and $6.48 million in FY2021.
- Five-year quarterly Change in Accrued Expenses spans a low of -$19.05 million in Q4 2023 and a high of $34.32 million in Q2 2026.
- The high point for year-over-year Change in Accrued Expenses in five years was Q2 2026 (growth of 380.7%); the low point was Q4 2022 (a decline of 64.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $34.32 million (Q2 2026), -$9.38 million (Q1 2026) and -$12.71 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Accrued Exp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 2.41 Bn |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 983.00 Mn |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | -87.00 Mn |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 756.00 Mn |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | - |
| 10 | Corcept Therapeutics | 7.99 Bn | 6.60 Bn | 335.86 Mn | 11.13 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 11.13 Mn |
| Jun 30, 2026 | 34.32 Mn |
| Mar 31, 2026 | -9.38 Mn |
| Dec 31, 2025 | -13.24 Mn |
| Sep 30, 2025 | 15.90 Mn |
| Jun 30, 2025 | 7.14 Mn |
| Mar 31, 2025 | -5.87 Mn |
| Dec 31, 2024 | 10.71 Mn |
| Sep 30, 2024 | 19.62 Mn |
| Jun 30, 2024 | -1.21 Mn |
| Mar 31, 2024 | 9.11 Mn |
| Dec 31, 2023 | -19.05 Mn |
| Sep 30, 2023 | 17.42 Mn |
| Jun 30, 2023 | 11.25 Mn |
| Mar 31, 2023 | 8.03 Mn |
| Dec 31, 2022 | 1.18 Mn |
| Sep 30, 2022 | 4.67 Mn |
| Jun 30, 2022 | -7.92 Mn |
| Mar 31, 2022 | 5.00 Mn |
| Dec 31, 2021 | 3.36 Mn |
API Access
Corcept Therapeutics Change in Accrued Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CORT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-accured-expenses", "ticker": "CORT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=CORT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();